Loading...
Zoetis Inc.
ZTS•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$151.19
$3.82(2.59%)
Zoetis Inc. (ZTS) AI-Powered Stock Analysis
See how Zoetis Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerZoetis Inc. (ZTS) Stock Overall Grade
Zoetis Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
A
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Zoetis Inc.'s overall stock rating.
Forecast
B+Score
79/100Financial Growth
A+Score
100/100Fundamental Growth
A+Score
96/100Key Ratios
B+Score
73/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
75/100Zoetis Inc. (ZTS) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 79/100 (B+), reflecting high confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (96/100, A+) highlight its stability, while Key Ratios (73/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Zoetis Inc. stock grade, including financials, comparisons, and forecasts.